Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition ...Middle East

- Data spans eleven presentations across both solid tumors and hematologic malignancies, providing added understanding of the potential benefit these therapies bring to patients - ORSERDU data reinforce its key role in the treatment of ER+, HER2- advanced or metastatic breast cancer (mBC)...

Hence then, the article about menarini group announces new data on orserdu elacestrant at the 2023 san antonio breast cancer symposium and on elzonris tagraxofusp erzs at the 65th american society of hematology annual meeting and exposition was published today ( Tuesday 21/11/2023 - 01:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition )

Also on site :

• Oddity Tech Ltd. Group Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ODD
• ‘Technofascism’: Critics accuse Palantir of pushing AI war doctrine
• Jennifer Aniston Shares Surprising Reaction To Ex-Husband Justin Theroux's Baby Announcement